Does LATANOPROSTENE BUNOD Cause Ocular hyperaemia? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Ocular hyperaemia have been filed in association with LATANOPROSTENE BUNOD (Vyzulta). This represents 10.3% of all adverse event reports for LATANOPROSTENE BUNOD.
56
Reports of Ocular hyperaemia with LATANOPROSTENE BUNOD
10.3%
of all LATANOPROSTENE BUNOD reports
0
Deaths
1
Hospitalizations
How Dangerous Is Ocular hyperaemia From LATANOPROSTENE BUNOD?
Of the 56 reports, 1 (1.8%) required hospitalization.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LATANOPROSTENE BUNOD. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does LATANOPROSTENE BUNOD Cause?
Eye irritation (64)
Eye pain (56)
Intraocular pressure increased (43)
Drug ineffective (31)
Product quality issue (29)
Vision blurred (28)
Death (27)
Headache (22)
Instillation site pain (21)
Eye pruritus (20)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which LATANOPROSTENE BUNOD Alternatives Have Lower Ocular hyperaemia Risk?
LATANOPROSTENE BUNOD vs LATANOPROST\NETARSUDIL
LATANOPROSTENE BUNOD vs LATANOPROST\TIMOLOL
LATANOPROSTENE BUNOD vs LATISSE
LATANOPROSTENE BUNOD vs LATUDA
LATANOPROSTENE BUNOD vs LAZERTINIB